Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Aptamers can improve wound healing and promote hair growth.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

XEDAR triggers a specific signaling pathway in cells.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Some gonadal hormone drugs can block filovirus entry into cells.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

A new compound may treat benign prostatic hyperplasia better than finasteride.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

RXR agonists may promote hair growth in humans.

New compounds with carborane showed anti-androgen effects similar to flutamide.